Manufacturer record
Indo Rama Health Care Pvt.Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Indo Rama Health Care Pvt.Ltd were declared Not of Standard Quality between May 2025 and May 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: DT2503015A, Telmisartan Tablets IP 40 mg (exp Feb 2027). SDTL, Andhra Pradesh, Vijayawada (state lab) found it not of standard quality: Dissolution Test. Listed in the May 2026 alert.
Records by type
2 records linked to Indo Rama Health Care Pvt.Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Telmisartan Tablets IP 40 mg | Batch DT2503015AMfg Mar 2025 · Exp Feb 2027 | Dissolution TestDissolution | SDTL, Andhra Pradesh, VijayawadaState lab | May 2026 |
| Spnflox-OZ Tablets (Ofloxacin &OrnidazoleTablets IP) | Batch DT240523BMfg May 2024 · Exp Apr 2026 | Description of TabletsDescription | KarnatakaState lab | May 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.